134 related articles for article (PubMed ID: 35775365)
21. Cannabidiol as a potential treatment for psychosis.
Schubart CD; Sommer IE; Fusar-Poli P; de Witte L; Kahn RS; Boks MP
Eur Neuropsychopharmacol; 2014 Jan; 24(1):51-64. PubMed ID: 24309088
[TBL] [Abstract][Full Text] [Related]
22. Dysfunctional insular connectivity during reward prediction in patients with first-episode psychosis.
Schmidt A; Palaniyappan L; Smieskova R; Simon A; Riecher-Rössler A; Lang UE; Fusar-Poli P; McGuire P; Borgwardt SJ
J Psychiatry Neurosci; 2016 Oct; 41(6):367-376. PubMed ID: 26854756
[TBL] [Abstract][Full Text] [Related]
23. Brain responses to different types of salience in antipsychotic naïve first episode psychosis: An fMRI study.
Knolle F; Ermakova AO; Justicia A; Fletcher PC; Bunzeck N; Düzel E; Murray GK
Transl Psychiatry; 2018 Sep; 8(1):196. PubMed ID: 30242202
[TBL] [Abstract][Full Text] [Related]
24. Reward anticipation in individuals with subclinical psychotic experiences: A functional MRI approach.
Michielse S; Lange I; Bakker J; Goossens L; Verhagen S; Papalini S; Wichers M; Lieverse R; Schruers K; van Amelsvoort T; van Os J; Murray GK; Marcelis M
Eur Neuropsychopharmacol; 2019 Dec; 29(12):1374-1385. PubMed ID: 31685359
[TBL] [Abstract][Full Text] [Related]
25. The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging study.
Bloomfield MAP; Yamamori Y; Hindocha C; Jones APM; Yim JLL; Walker HR; Statton B; Wall MB; Lees RH; Howes OD; Curran VH; Roiser JP; Freeman TP
Psychopharmacology (Berl); 2022 May; 239(5):1539-1549. PubMed ID: 35445839
[TBL] [Abstract][Full Text] [Related]
26. Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.
Bhattacharyya S; Morrison PD; Fusar-Poli P; Martin-Santos R; Borgwardt S; Winton-Brown T; Nosarti C; O' Carroll CM; Seal M; Allen P; Mehta MA; Stone JM; Tunstall N; Giampietro V; Kapur S; Murray RM; Zuardi AW; Crippa JA; Atakan Z; McGuire PK
Neuropsychopharmacology; 2010 Feb; 35(3):764-74. PubMed ID: 19924114
[TBL] [Abstract][Full Text] [Related]
27. Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study.
Winton-Brown TT; Allen P; Bhattacharyya S; Borgwardt SJ; Fusar-Poli P; Crippa JA; Seal ML; Martin-Santos R; Ffytche D; Zuardi AW; Atakan Z; McGuire PK
Neuropsychopharmacology; 2011 Jun; 36(7):1340-8. PubMed ID: 21412224
[TBL] [Abstract][Full Text] [Related]
28. Cannabidiol (CBD) as a novel treatment in the early phases of psychosis.
Chesney E; Oliver D; McGuire P
Psychopharmacology (Berl); 2022 May; 239(5):1179-1190. PubMed ID: 34255100
[TBL] [Abstract][Full Text] [Related]
29. Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypotheses.
Lawn W; Freeman TP; Pope RA; Joye A; Harvey L; Hindocha C; Mokrysz C; Moss A; Wall MB; Bloomfield MA; Das RK; Morgan CJ; Nutt DJ; Curran HV
Psychopharmacology (Berl); 2016 Oct; 233(19-20):3537-52. PubMed ID: 27585792
[TBL] [Abstract][Full Text] [Related]
30. Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.
Fusar-Poli P; Crippa JA; Bhattacharyya S; Borgwardt SJ; Allen P; Martin-Santos R; Seal M; Surguladze SA; O'Carrol C; Atakan Z; Zuardi AW; McGuire PK
Arch Gen Psychiatry; 2009 Jan; 66(1):95-105. PubMed ID: 19124693
[TBL] [Abstract][Full Text] [Related]
31. Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users.
Hindocha C; Freeman TP; Schafer G; Gardener C; Das RK; Morgan CJ; Curran HV
Eur Neuropsychopharmacol; 2015 Mar; 25(3):325-34. PubMed ID: 25534187
[TBL] [Abstract][Full Text] [Related]
32. fMRI study of cannabidiol-induced changes in attention control in treatment-resistant epilepsy.
Allendorfer JB; Nenert R; Bebin EM; Gaston TE; Grayson LE; Hernando KA; Houston JT; Hansen B; Szaflarski JP
Epilepsy Behav; 2019 Jul; 96():114-121. PubMed ID: 31129526
[TBL] [Abstract][Full Text] [Related]
33. The relationship between cannabidiol and psychosis: A review.
Silva TB; Balbino CQ; Weiber AF
Ann Clin Psychiatry; 2015 May; 27(2):134-41. PubMed ID: 25954940
[TBL] [Abstract][Full Text] [Related]
34. Functional Connectivity in Antipsychotic-Treated and Antipsychotic-Naive Patients With First-Episode Psychosis and Low Risk of Self-harm or Aggression: A Secondary Analysis of a Randomized Clinical Trial.
Chopra S; Francey SM; O'Donoghue B; Sabaroedin K; Arnatkeviciute A; Cropley V; Nelson B; Graham J; Baldwin L; Tahtalian S; Yuen HP; Allott K; Alvarez-Jimenez M; Harrigan S; Pantelis C; Wood SJ; McGorry P; Fornito A
JAMA Psychiatry; 2021 Sep; 78(9):994-1004. PubMed ID: 34160595
[TBL] [Abstract][Full Text] [Related]
35. Individual and combined effects of cannabidiol and Δ
Wall MB; Freeman TP; Hindocha C; Demetriou L; Ertl N; Freeman AM; Jones AP; Lawn W; Pope R; Mokrysz C; Solomons D; Statton B; Walker HR; Yamamori Y; Yang Z; Yim JL; Nutt DJ; Howes OD; Curran HV; Bloomfield MA
J Psychopharmacol; 2022 Jun; 36(6):732-744. PubMed ID: 35596578
[TBL] [Abstract][Full Text] [Related]
36. A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation.
Zuardi AW; Crippa JA; Hallak JE; Bhattacharyya S; Atakan Z; Martin-Santos R; McGuire PK; Guimarães FS
Curr Pharm Des; 2012; 18(32):5131-40. PubMed ID: 22716160
[TBL] [Abstract][Full Text] [Related]
37. Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts: A Naturalistic Controlled Study.
Sainz-Cort A; Jimenez-Garrido D; Muñoz-Marron E; Viejo-Sobera R; Heeroma J; Bouso JC
J Clin Psychopharmacol; 2021 Sep-Oct 01; 41(5):561-570. PubMed ID: 34412109
[TBL] [Abstract][Full Text] [Related]
38. Probing the endocannabinoid system in healthy volunteers: Cannabidiol alters fronto-striatal resting-state connectivity.
Grimm O; Löffler M; Kamping S; Hartmann A; Rohleder C; Leweke M; Flor H
Eur Neuropsychopharmacol; 2018 Jul; 28(7):841-849. PubMed ID: 29887287
[TBL] [Abstract][Full Text] [Related]
39. The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial.
Boggs DL; Surti T; Gupta A; Gupta S; Niciu M; Pittman B; Schnakenberg Martin AM; Thurnauer H; Davies A; D'Souza DC; Ranganathan M
Psychopharmacology (Berl); 2018 Jul; 235(7):1923-1932. PubMed ID: 29619533
[TBL] [Abstract][Full Text] [Related]
40. Cannabidiol and Sodium Nitroprusside: Two Novel Neuromodulatory Pharmacological Interventions to Treat and Prevent Psychosis.
Crippa JA; Hallak JE; Abílio VC; de Lacerda AL; Zuardi AW
CNS Neurol Disord Drug Targets; 2015; 14(8):970-8. PubMed ID: 26350340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
